Seattle Genetics Commits To Simultaneous Confirmatory Trials For Adcetris

FDA approves the antibody-drug conjugate for late stage Hodgkins lymphoma and systemic anaplastic large cell lymphoma Aug. 19.

More from Archive

More from Pink Sheet